Skip to main content
Premium Trial:

Request an Annual Quote

HGS Shares Rise After Stock Split Approved

NEW YORK, Sept 19 - Human Genome Sciences (Nasdaq: HGSI) stock jumped 9 13/16, or 6.8 percent, to 153 13/16 in mid-morning trading Tuesday following an announcement on  Monday after the close of trading that the company’s board had approved a two-for-one stock split.

Shareholders will receive an additional common share for each share held at close-of-business on Sept. 28. The additional shares will be delivered on or about Oct. 5.

After the completion of the split HGS will have 56 million shares outstanding.

This is the second split of HGS common stock since the company’s IPO in December of 1993.

HGS's shares reached a 52-week high of 232 3/4 in early March.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.